2002
DOI: 10.1074/jbc.m110345200
|View full text |Cite
|
Sign up to set email alerts
|

Activation of Caspase Pathways during Iron Chelator-mediated Apoptosis

Abstract: Iron chelators have traditionally been used in the treatment of iron overload. Recently, chelators have also been explored for their ability to limit oxidant damage in cardiovascular, neurologic, and inflammatory disease as well as to serve as anti-cancer agents. To determine the mechanism of cell death induced by iron chelators, we assessed the time course and pathways of caspase activation during apoptosis induced by iron chelators. We report that the chelator tachpyridine sequentially activates caspases 9, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
61
1

Year Published

2004
2004
2014
2014

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 76 publications
(66 citation statements)
references
References 42 publications
(47 reference statements)
4
61
1
Order By: Relevance
“…205 Furthermore, apoptosis mediated by Tachpyridine was not prevented by blocking the CD95 death receptor pathway with a Fas-associated death domain protein dominant-negative mutant. 206 In addition, this chelator-mediated cell death was blocked in cells pre-treated with Bcl-XL and a dominant-negative caspase-9 expression vector. 206 Iron and the Cell Cycle Induction of apoptosis by Dp44mT and DFO was accompanied by a decrease in Bcl-2 expression, an increase in Bax and also cytochrome c efflux from the mitochondrion.…”
Section: The Molecular Targets Of Iron Chelators and Their Effects Onmentioning
confidence: 99%
See 2 more Smart Citations
“…205 Furthermore, apoptosis mediated by Tachpyridine was not prevented by blocking the CD95 death receptor pathway with a Fas-associated death domain protein dominant-negative mutant. 206 In addition, this chelator-mediated cell death was blocked in cells pre-treated with Bcl-XL and a dominant-negative caspase-9 expression vector. 206 Iron and the Cell Cycle Induction of apoptosis by Dp44mT and DFO was accompanied by a decrease in Bcl-2 expression, an increase in Bax and also cytochrome c efflux from the mitochondrion.…”
Section: The Molecular Targets Of Iron Chelators and Their Effects Onmentioning
confidence: 99%
“…206 In addition, this chelator-mediated cell death was blocked in cells pre-treated with Bcl-XL and a dominant-negative caspase-9 expression vector. 206 Iron and the Cell Cycle Induction of apoptosis by Dp44mT and DFO was accompanied by a decrease in Bcl-2 expression, an increase in Bax and also cytochrome c efflux from the mitochondrion. 93,169 More recently, and similarly, DFO has been shown to induce apoptosis through down-regulation of the Bcl-2 protein and upregulation of Bax in malignant oral keratinocytes.…”
Section: The Molecular Targets Of Iron Chelators and Their Effects Onmentioning
confidence: 99%
See 1 more Smart Citation
“…[46][47][48] One mechanism by which chelators and other factors (eg, oxidative stress) cause tumor cell death may be through the induction of apoptosis. 22,24,[49][50][51][52][53][54][55][56] However, the precise mechanisms involved in chelator-mediated apoptosis remain unclear, particularly for aroylhydrazone ligands.The caspase enzymes are common executors of apoptosis. 52,57,58 Two caspase-activating cascades that regulate apoptosis have been described; one is initiated through death receptors (eg, CD95), and the other is triggered by changes in mitochondrial integrity.…”
mentioning
confidence: 99%
“…using Western blotting. 9) As shown in Fig. 8, procapase-3 was proteolytically activated after treated with ME 8 mM for 36 h, and cleaved fragments were detected at the same time.…”
Section: Resultsmentioning
confidence: 87%